mRNA Cancer Vaccine Elicits T Cell Response and Eliminates Tumors in Mice - Genetic Engineering & Biotechnology News

An mRNA-based cancer vaccine, delivered directly into the lymphatic system for a more potent response, eliminates tumors and prevents recurrence in mice.

A challenge for in vivo applications of mRNA technology, and cancer vaccines specifically, remains the targeted delivery of messenger RNA (mRNA) to desired organs. For mRNA vaccines, targeted deliver… [+3535 chars]

full article...